ARTICLE | Clinical News
AP214: Phase II started
October 26, 2009 7:00 AM UTC
Action Pharma began a double-blind, placebo-controlled, Danish Phase II trial to evaluate intravenous AP214 in 42 patients undergoing cardiac surgery. The company licensed worldwide rights to develop ...